Author: FX
Is bitcoin gearing up for a long-term reversal? BTC/USD is already testing the neckline of the chart pattern, which means that we might be in for a big move pretty soon! Check out this formation I’m watching on the daily time frame. Bitcoin (BTC/USD) Daily Chart by TV Bitcoin made a couple of failed attempts to bust through the ceiling near $32,500 recently, creating a double top pattern. Price is now down to the neckline at $25,500, and a break below support could confirm the reversal. If that happens, BTC/USD could tumble by the same height as the chart formation.…
Share: Gold price trades with a positive bias for the second straight day and holds above the 200-day SMA. Subdued US Dollar price action and looming recession risks offer some support to the XAU/USD. The upside seems limited ahead of the US CPI on Wednesday and Thursday’s ECB policy meeting. Gold price attracts some dip-buying in the vicinity of the very important 200-day Simple Moving Average (SMA) support during the Asian session on Tuesday and stalls the overnight pullback from the $1,930 area, or a four-day high. The XAU/USD currently trades around the $1,923 region, up slightly for the…
AerCap's stock falls in extended trading on GE plan to sell stock Source link
© Reuters. A general view of the Phillips 66 refinery, as seen from Rodeo, California, the oldest oil refining town in the American West, U.S. March 2, 2023. REUTERS/Nathan Frandino By Stephanie Kelly (Reuters) – futures hovered just above $90 a barrel on Tuesday, as investors awaited a slew of macroeconomic data due later this week that could indicate whether Europe and the U.S. continue to hike interest rates. The international benchmark Brent contract dipped 6 cents to $90.58 a barrel at 0003 GMT, while U.S. West Texas Intermediate crude futures edged 2 cents lower to $87.27. Brent reached $90…
Ueda’s interview response flagged a possible end to negative rates from the Bank as well as a possible date for the change. The massive change of tone from the Governor rocked USD/JPY to its biggest drop in months. Summary and links here ICYMI:Deutsche Bank are expecting more detailed information from the Bank of Japan meeting next week (statement will be on September 22, Japan time, sometime around 0300 GMT, which is 11pm on the 21st, US Eastern time). DD have switched up their forecasts also:now expect BOJ Yield Curve Control (YCC) to end in October (DB were previously forecasting this…
Share: During the Asian session, New Zealand will report Electronic Card Retails Sales data and Australian Confidence surveys are due. Later in the day, the key reports will be the UK employment data and the German ZEW survey. Here is what you need to know on Tuesday, September 12: The positive streak of the US Dollar Index (DXY) finally ended after several consecutive days of gains. The pullback was triggered by some improvement in risk sentiment. The Nasdaq increased by 1.14%, while the S&P 500 climbed 0.67%. As a result, the DXY retreated from above 105.00 to 104.55.…
Trade Smarter – Sign up for the DailyFX Newsletter Receive timely and compelling market commentary from the DailyFX team Subscribe to Newsletter GOLD PRICE FORECASTGold advanced on Monday on the back of a weaker U.S. dollar, but gains were limited as traders avoided taking large directional positions ahead of Wednesday’s U.S. inflation data, which may have a significant impact on financial markets and set the tone for precious metals.A closer look at XAU/USD’s daily chart reveals a lack of conviction in recent days, with volatility subdued and prices wavering around technical resistance at $1,925/$1,935, where the 50-day simple moving average…
hapabapa Bicycle Therapeutics (NASDAQ:BCYC) traded ~9% higher on Monday after the oncology-focused biotech said that the U.S. FDA agreed on plans for a Phase 2/3 registrational trial for its bladder cancer therapy BT8009. The trial named Duravelo-2 is designed to support a potential accelerated approval for BT8009 in metastatic bladder cancer as a first-line and second-line option, the company said, adding that the global trial will begin in Q1 2024. The decision to focus on untreated patients is in line with the FDA’s Project FrontRunner, an initiative to encourage developers to seek approval for new cancer drugs in earlier-line settings…
© Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo (Reuters) -The U.S. Food and Drug Administration on Monday authorized updated COVID-19 vaccines that closely match the widely circulating Omicron variants, allowing the deployment of the shots to start this month. The agency approved the shots, which target the XBB.1.5 subvariant, for emergency use from manufacturers Pfizer (NYSE:) and its German partner BioNTech SE (NASDAQ:), and Moderna (NASDAQ:). The FDA authorization comes after a late summer rise in cases, at a time the…
Uncle Sam has another batch of inflation figures comin’ right up! Can these still make or break Fed tightening expectations? And how might the U.S. dollar react to the actual results? Here’s what market watchers are expecting for the U.S. August CPI report. Event in Focus: U.S. headline and core CPI readings for August 2023 When Will it Be Released: September 13, 2023 (Wednesday), 12:30 pm GMT Use our Forex Market Hours tool to convert GMT to your local time zone. Expectations: U.S. headline consumer price index m/m: +0.6% forecast vs. +0.2% previous U.S. headline consumer price index y/y: +3.6%…